Ware Kuschner, M.D.
Academic Appointments
- Associate Professor - Med Center Line, Medicine - Pulmonary & Critical Care Med
Contact Information
- Academic
Offices
Personal Information Email
Professional Snapshot
Administrative Appointments
- Associate Medical Director, Respiratory Therapy, Veterans Affairs Palo Alto Health Care System (1997 - present)
- Chair, Clinical Bioethics Committee and Ethics Consultation Service, Veterans Affairs Palo Alto Health Care System (2001 - present)
- Editorial Board, Pulmonary and Critical Care Update, American College of Chest Physicians (2004 - present)
- Chair, Occupational and Environmental Health NetWork Steering Committee, American College of Chest Physicians (2007 - present)
- Member, IRB Panel 3, Stanford University (2008 - present) View All 6administrative appointments of Ware Kuschner
Honors and Awards
- Research Award, Foundation for Fellows in Asthma Research (1995)
- Walter Travel Fund Award, American Lung Association (1995)
- Research Award, Foundation for Occupational Health and Research (1996)
- Cecile Lehman Mayer Research Award Finalist, American College of Chest Physicians (1996)
- Faculty Teaching Award, Division of Pulmonary and Critical Care Medicine, Stanford University (2000)
Professional Education
| Fellowship: | Univ. of Calif., San Francisco, Pulmonary & Crit. Care Medicine (1996) |
| Residency: | Columbia-Presbyterian Medical Ctr, Internal Medicine (1992) |
| M.D.: | Columbia University, Medical Education (1989) |
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Broncus Technologies, Inc. |
Scientific Focus
Research Interests
My principal research interest is occupational and environmental lung disease. I have special interest in the health effects of fibers, particles, vapors, gases, dusts, and fumes in exposed workers. I also conduct research on the health effects of indoor and outdoor air pollution in humans. My work includes experimental human research studying the acute effects of biomass fuel smoke inhalation. I also conduct observational analyses assessing exposure-effects relationships in selected populations.
Clinical Trials
- A 24 Week,Randomized Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of 18 mcg of Tiotropium Inhalation Capsules Administered by HandiHaler Once-daily Plus prn Albuterol vs.Placebo Plus prn Albuterol(SALBUTAMOL) in COPD Subjects Naïve to Maintenance Therapy Recruiting
- A Comparison of SymbicortŪ pMDI 2 x 160/4.5 ėg Bid and 2 x 80/4.5 ėg Bid With Formoterol TurbuhalerŪ 2 x 4.5 ėg Bid Placebo in Patients With COPD No longer recruiting
- Assessing the rate of decline of lunf function with Tiotropium 18 mcg inhalation capsule once daily in patients with chronic obstructive pulmonary disease No longer recruiting
- Effect of roflumilast on exacerbation rate in patients with COPD. No longer recruiting
Publications
- The effect of an inhaled corticosteroid on glucose control in type 2 diabetes. Clin Med Res. 2009; (1-2): 14-20
- Occupational history quality in patients with newly documented, clinician-diagnosed chronic bronchitis. Chest. 2009; (2): 378-83
- Implementation of ICU palliative care guidelines and procedures: a quality improvement initiative following an investigation of alleged euthanasia. Chest. 2009; (1): 26-32
- Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009; (9696): 1171-8
- Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet. 2009; (9691): 685-94
Help